Keen M L, Gotch F A
Nephrology Medical Affairs, Amgen Inc., Thousand Oaks, California, USA.
Int J Artif Organs. 2007 Nov;30(11):971-9. doi: 10.1177/039139880703001105.
Hemodialysis patients lack the normal mechanisms to regulate body water volume and osmolality. The dialysis treatment is expected to adequately regulate both body water volume and body Na+ content, which is the primary action determining body water osmolality. Data in subjects with normal renal function indicate that an individual has a specific osmolality value above which thirst is generated and fluid will be ingested. This specific osmolality value or "setpoint" varies among individuals, but is quite reproducible within an individual. It was postulated that hemodialysis patients also may have a Na+ 'setpoint', which if increased by the use of higher dialysate Na+ concentration, might be associated with increased interdialytic weight gain and blood pressure.
Monthly laboratory and treatment data were abstracted on 58 hemodialysis patients and included pre- and post-dialysis serum Na+ concentrations, interdialytic weight gain and blood pressure over 9 to 16 months. The Na+ concentrations were averaged to determine the individual Na+ 'setpoint' and the Na+ gradient (Dialysis Na+ concentration - mean Na+ concentration) was determined for each patient.
Linear regression analyses showed that there was a statistically significant association between the magnitude of the Na+ gradient and interdialytic weight gain and blood pressure.
These data suggest that interdialytic weight gain in individual patients may be associated with the use of dialysate Na+ concentration in excess of the patient's desired Na+ 'setpoint'. More individualization of dialysate Na+ concentration may be indicated.
血液透析患者缺乏调节身体水容量和渗透压的正常机制。透析治疗预期能充分调节身体水容量和体内钠含量,而体内钠含量是决定身体水渗透压的主要因素。肾功能正常受试者的数据表明,个体有一个特定的渗透压值,超过该值会产生口渴感并促使其摄入液体。这个特定的渗透压值或“设定点”因人而异,但在个体内部相当稳定。据推测,血液透析患者也可能有一个钠“设定点”,如果通过使用更高的透析液钠浓度使其升高,可能会导致透析间期体重增加和血压升高。
提取了58例血液透析患者的月度实验室和治疗数据,包括透析前和透析后的血清钠浓度、9至16个月的透析间期体重增加量和血压。计算钠浓度平均值以确定个体钠“设定点”,并为每位患者计算钠梯度(透析液钠浓度 - 平均钠浓度)。
线性回归分析表明,钠梯度大小与透析间期体重增加和血压之间存在统计学显著关联。
这些数据表明,个体患者的透析间期体重增加可能与使用超过患者期望钠“设定点”的透析液钠浓度有关。可能需要更个体化地设定透析液钠浓度。